Read + Share
Lv H, Wang S, Liang Z, Yu W, et al. Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese
females 9-45 years of age: A phase 3 open-label study. Vaccine 2022 Apr 26. pii: S0264-410X(22)00205.
PMID: 35487814
|
 |
|
Lv H, Wang S, Liang Z, Yu W, et al. Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese
females 9-45 years of age: A phase 3 open-label study. Vaccine 2022 Apr 26. pii: S0264-410X(22)00205.
PMID: 35487814
|
|
|
|